Prime Capital Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.9M | Sell |
23,814
-9,181
| -28% | -$4.41M | 0.12% | 136 |
|
|
2026
Q1 | $16.2M | Sell |
32,995
-979
| -3% | -$531K | 0.19% | 105 |
|
|
2025
Q4 | $19.7M | Buy |
33,974
+317
| +0.9% | +$179K | 0.24% | 74 |
|
|
2025
Q3 | $16.3M | Buy |
33,657
+7,981
| +31% | +$3.71M | 0.2% | 84 |
|
|
2025
Q2 | $10.4M | Sell |
25,676
-6,928
| -21% | -$2.9M | 0.14% | 126 |
|
|
2025
Q1 | $16.2M | Buy |
32,604
+24,713
| +313% | +$13.4M | 0.19% | 98 |
|
|
2024
Q4 | $4.11M | Sell |
7,891
-564
| -7% | -$310K | 0.06% | 211 |
|
|
2024
Q3 | $5.23M | Sell |
8,455
-2,220
| -21% | -$1.31M | 0.07% | 177 |
|
|
2024
Q2 | $5.9M | Sell |
10,675
-1,223
| -10% | -$701K | 0.09% | 163 |
|
|
2024
Q1 | $6.92M | Sell |
11,898
-6,599
| -36% | -$3.7M | 0.1% | 162 |
|
|
2023
Q4 | $9.82M | Buy |
18,497
+5,364
| +41% | +$2.6M | 0.15% | 123 |
|
|
2023
Q3 | $6.65M | Buy |
13,133
+4,671
| +55% | +$2.49M | 0.14% | 124 |
|
|
2023
Q2 | $4.42M | Buy |
8,462
+386
| +5% | +$208K | 0.09% | 173 |
|
|
2023
Q1 | $4.65M | Buy |
8,076
+2,702
| +50% | +$1.52M | 0.19% | 100 |
|
|
2022
Q4 | $2.96M | Buy |
5,374
+304
| +6% | +$161K | 0.11% | 139 |
|
|
2022
Q3 | $2.57M | Sell |
5,070
-14,389
| -74% | -$8.05M | 0.15% | 103 |
|
|
2022
Q2 | $10.6M | Buy |
19,459
+10,340
| +113% | +$5.69M | 0.63% | 27 |
|
|
2022
Q1 | $6.08M | Sell |
9,119
-83
| -0.9% | -$47.7K | 0.34% | 57 |
|
|
2021
Q4 | $6.14M | Buy |
9,202
+4,571
| +99% | +$2.85M | 0.33% | 60 |
|
|
2021
Q3 | $2.65M | Sell |
4,631
-3,562
| -43% | -$1.96M | 0.17% | 109 |
|
|
2021
Q2 | $4.13M | Buy |
8,193
+642
| +9% | +$303K | 0.24% | 89 |
|
|
2021
Q1 | $3.45M | Buy |
7,551
+18
| +0.2% | +$8.59K | 0.25% | 87 |
|
|
2020
Q4 | $3.51M | Buy |
7,533
+103
| +1% | +$48.3K | 0.27% | 74 |
|
|
2020
Q3 | $3.28M | Buy |
7,430
+2,948
| +66% | +$1.22M | 0.28% | 72 |
|
|
2020
Q2 | $1.62M | Sell |
4,482
-6,574
| -59% | -$2.2M | 0.15% | 117 |
|
|
2020
Q1 | $3.14M | Sell |
11,056
-5,143
| -32% | -$1.62M | 0.37% | 50 |
|
|
2019
Q4 | $5.26M | Sell |
16,199
-755
| -4% | -$229K | 0.6% | 23 |
|
|
2019
Q3 | $4.94M | Buy |
16,954
+8,454
| +99% | +$2.42M | 0.76% | 31 |
|
|
2019
Q2 | $2.5M | Buy |
8,500
+8,100
| +2,025% | +$2.23M | 0.46% | 63 |
|
|
2019
Q1 | $109K | Hold |
400
| – | – | 0.03% | 154 |
|
|
2018
Q4 | $90K | Sell |
400
-220
| -35% | -$51.6K | 0.03% | 139 |
|
|
2018
Q3 | $151K | Buy |
620
+495
| +396% | +$114K | 0.05% | 137 |
|
|
2018
Q2 | $26K | Buy |
+125
| New | +$26.5K | 0.01% | 227 |
|
|
2018
Q1 | – | Sell |
-18
| Closed | -$3K | – | 274 |
|
|
2017
Q4 | $3K | Buy |
+18
| New | +$3.45K | ﹤0.01% | 231 |
|
Other funds holding TMO
Prime Capital Investment Advisors's TMO Position: Q2 2026 in Review
Prime Capital Investment Advisors reduced its Thermo Fisher Scientific (TMO) stake by 28% in Q2 2026, selling an estimated $4.41M and leaving 23,814 shares worth $11.9M. The position accounts for 0.12% of the portfolio, ranked #136.
Prime Capital Investment Advisors first reported a position in TMO in Q4 2017 and has held it in 34 quarters since. The position peaked at $19.7M in Q4 2025. 2,022 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Prime Capital Investment Advisors held 23,814 shares of Thermo Fisher Scientific worth $11.9M as of Q2 2026.
- Prime Capital Investment Advisors sold 9,181 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.41M.
- Thermo Fisher Scientific made up 0.12% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #136 holding.
- Prime Capital Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 34 quarters since.
- Prime Capital Investment Advisors's Thermo Fisher Scientific position peaked at $19.7M in Q4 2025.
- 2,022 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.